HOME >> MEDICINE >> NEWS
Little change in suicidal thoughts, plans or attempts in US

Despite a substantial increase in treatment for suicide attempts, no significant decrease occurred in the number of persons reporting suicide-related behaviors in the U.S. in the 1990s, according to a study in the May 25 issue of JAMA.

Suicide is one of the leading causes of death worldwide, according to background information in the article. As a result, the World Health Organization and the U.S. surgeon general have highlighted the need for more comprehensive data on the occurrence of suicidal thoughts and attempts, with the assumption that such data would be useful for planning national health care policy, as well as for evaluating efforts to reduce suicide and suicide-related behaviors.

Ronald C. Kessler, Ph.D., of Harvard Medical School, Boston, and colleagues examined nationally representative general-population trend data on the 12-month prevalence and treatment of suicide-related behaviors. Data came from the 1990-1992 National Comorbidity Survey and the 2001-2003 National Comorbidity Survey Replication. These surveys asked identical questions to 9,708 people aged 18 to 54 years about the past year's occurrence of suicidal ideation, plans, gestures, attempts, and treatment. Face-to-face interviews were administered in the homes of respondents.

The researchers found that no significant changes occurred between 1990-1992 and 2001-2003 in suicidal ideation (2.8 percent vs. 3.3 percent), plans (0.7 percent vs. 1.0 percent), gestures (0.3 percent vs. 0.2 percent), or attempts (0.4 percent-0.6 percent). Treatment increased dramatically among ideators who made a gesture (40.3 percent vs. 92.8 percent) and among ideators who made an attempt (49.6 percent vs. 79.0 percent). The authors add that " we found that risk of suicide-related behaviors is consistently elevated in several vulnerable subgroups, including the young, women, individuals with low education, and individuals lacking stable relationships or employment."

Previous stud
'"/>

Contact: John Lacey
617-432-0442
JAMA and Archives Journals
24-May-2005


Page: 1 2

Related medicine news :

1. Little difference between human insulin and faster-acting drugs
2. Little evidence behind bronchodilator therapy for cystic fibrosis
3. Little evidence found for IVF as most effective infertility treatment
4. Little answers to worlds biggest problems
5. Backache sufferers who fear pain change movements
6. ACP commends proposed changes to payments for physician work at nursing facilities
7. Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
8. Exploring better ways to determine when to change the course of treatment
9. Policy changes have direct effect on nursing home care
10. Personality changes may help detect form of dementia
11. Public health impact of climate change, poverty, disaster response and housing design

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Little change suicidal thoughts plans attempts

(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
Cached News: